Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression
- PMID: 21781377
- PMCID: PMC3830677
- DOI: 10.1017/S0033291711001279
Change in psychosocial functioning and depressive symptoms during acute-phase cognitive therapy for depression
Abstract
Background: Major depressive disorder (MDD) is highly prevalent, is recurrent, and impairs people's work, relationships and leisure. Acute-phase treatments improve psychosocial impairment associated with MDD, but how these improvements occur is unclear. In this study, we tested the hypotheses that reductions in depressive symptoms exceed, precede and predict improvements in psychosocial functioning.
Method: Patients with recurrent MDD (n=523; 68% women, 81% Caucasian, mean age 42 years) received acute-phase cognitive therapy (CT). We measured functioning and symptom severity with the Social Adjustment Scale - Self-Report (SAS-SR), Range of Impaired Functioning Tool (RIFT), Beck Depression Inventory (BDI), Hamilton Rating Scale for Depression (HAMD) and Inventory for Depressive Symptomatology - Self-Report (IDS-SR). We tested cross-lagged correlations between functioning and symptoms measured at baseline and the beginning, middle and end of acute-phase CT.
Results: Pre- to post-treatment improvement in psychosocial functioning and depressive symptoms was large and intercorrelated. Depressive symptoms improved more and sooner than did psychosocial functioning. However, among four assessments across the course of treatment, improvements in functioning more strongly predicted later improvement in symptoms than vice versa.
Conclusions: Improvements in psychosocial functioning and depressive symptoms correlate substantially during acute-phase CT, and improvements in functioning may play a role in subsequent symptom reduction during acute-phase CT.
Conflict of interest statement
Declaration of Interest:
During the past two years Dr. Thase has consulted with, served on advisory boards for, or received honoraria for talks from: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Lundbeck, MedAvante, Inc., Neuronetics, Inc., Novartis, Otsuka, Pamlab, Pfizer Pharmaceuticals, Schering-Plough, Shionogi, Shire US Inc., Supernus Pharmaceuticals, Takeda, Transcept Pharmaceuticals, and Wyeth Pharmaceuticals and he has received grant support from Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Otsuka, and Sepracor, Inc., in addition to funding from the NIMH. He has equity holdings for MedAvante, Inc. and has received royalties from American Psychiatric Publishing, Inc. (APPI), Guilford Publications, Herald House, and W.W. Norton & Company, Inc. Two books currently promoted by the APPI specifically pertain to cognitive therapy. Dr. Thase also discloses that his spouse is an employee of Embryon, Inc. (formerly Cardinal Health and Advogent), which does business with several pharmaceutical companies that market medications used to treat depression.
Dr. Jarrett’s medical center receives the fees from the cognitive therapy she provides to patients. Dr. Jarrett is a paid consultant to the NIMH.
Thomas Carmody has been a consultant for Cyberonics, Inc.
Figures



Similar articles
-
Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression.J Consult Clin Psychol. 2013 Aug;81(4):615-26. doi: 10.1037/a0032879. Epub 2013 Apr 29. J Consult Clin Psychol. 2013. PMID: 23627652 Free PMC article.
-
Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.J Affect Disord. 2016 Jul 15;199:148-56. doi: 10.1016/j.jad.2016.04.017. Epub 2016 Apr 13. J Affect Disord. 2016. PMID: 27104803 Free PMC article. Clinical Trial.
-
Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression.J Affect Disord. 2009 Jan;112(1-3):135-43. doi: 10.1016/j.jad.2008.04.004. Epub 2008 Jun 9. J Affect Disord. 2009. PMID: 18539337 Free PMC article. Clinical Trial.
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
-
It's complicated: The relation between cognitive change procedures, cognitive change, and symptom change in cognitive therapy for depression.Clin Psychol Rev. 2015 Nov;41:3-15. doi: 10.1016/j.cpr.2014.12.003. Epub 2014 Dec 24. Clin Psychol Rev. 2015. PMID: 25595660 Free PMC article. Review.
Cited by
-
Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?J Affect Disord. 2019 Jan 1;242:150-158. doi: 10.1016/j.jad.2018.08.053. Epub 2018 Aug 25. J Affect Disord. 2019. PMID: 30176494 Free PMC article.
-
Nomothetic and idiographic symptom change trajectories in acute-phase cognitive therapy for recurrent depression.J Consult Clin Psychol. 2013 Aug;81(4):615-26. doi: 10.1037/a0032879. Epub 2013 Apr 29. J Consult Clin Psychol. 2013. PMID: 23627652 Free PMC article.
-
Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.J Affect Disord. 2014;167:37-43. doi: 10.1016/j.jad.2014.05.038. Epub 2014 Jun 2. J Affect Disord. 2014. PMID: 25082112 Free PMC article.
-
Longitudinal changes in somatic symptoms and family disagreements among depression and community groups: a 23-year study.BMC Psychiatry. 2015 Oct 8;15:240. doi: 10.1186/s12888-015-0619-2. BMC Psychiatry. 2015. PMID: 26449276 Free PMC article.
-
Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.J Affect Disord. 2016 Jul 15;199:148-56. doi: 10.1016/j.jad.2016.04.017. Epub 2016 Apr 13. J Affect Disord. 2016. PMID: 27104803 Free PMC article. Clinical Trial.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) American Psychiatric Association; Washington, DC: 2000.
-
- Barry ES, Naus MJ, Rehm LP. Depression and implicit memory: Understanding mood congruent memory bias. Cognitive Therapy and Research. 2004;28:387–414.
-
- Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford; 1979.
-
- Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571. - PubMed
-
- Bothwell S, Weissman MM. Social impairments four years after an acute depressive episode. American Journal of Orthopsychiatry. 1977;47:231–237. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials